Atopic dermatitis
Conditions
Interventions
Test product A is applied to the inner right forearm and test product B is applied to the inner left forearm twice daily (after waking up and bathing) for six weeks, two pushes each.
Test product B is
Sponsors
TeleBio Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Select those who meet all of the following conditions: - Women who are over 20 years old and not more than 60 years old. - Those with mild symptoms of atopic dermatitis (mild skin rash such as mild erythema, dry, and desquamate lesions of any size). - Those who have dryness and redness on the inner side of the right and left forearms. - Those who have indicated their willingness to participate in the study and who can consent to participate in the study after understanding the explanations.
Exclusion criteria
Exclusion criteria: Exclude those who meet at least one of the following conditions: (1) Patients with atopic dermatitis of moderate severity or higher (skin rash with severe inflammation such as lesions with erythema, papule, erosion, infiltration, lichenization, etc.) covering less than 10% of body surface area). (2) Patients taking oral steroids, antihistamines, antiallergic agents, immunosuppressive agents, or tranquilizers. (3) Patients who have had serious allergic symptoms due to the use of topical medicines, cosmetics, quasi-drugs, or other products in the past. (4) Those who have a serious disease and are considered inappropriate for inclusion. (5) Those who are under treatment or being outpatients due to illness (excluding the common cold and dental disease). (6) Those who have a family member who works for a pharmaceutical or cosmetics company. (7) Those who are participating or have participated within four weeks in other clinical trials or investigations involving the use of cosmetics, quasi-drugs, or food products. (8) Any other person who is judged to be inappropriate by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stratum corneum moisture content | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin observation by a dermatologist (at screening, start date, 3 weeks after start date, and 6 weeks after start date) - Physician's observation: dryness, desquamation, erythema, papules, scars - Subjective symptoms: itching, irritation Instrumental Measurement (at start date, 3 weeks after start date, and 6 weeks after start date) - Transepidermal water loss - Roughness, smoothness, and scale Others (at start date, 3 weeks after start date, and 6 weeks after start date) - Questionnaire on the usability of the subject diary and test product, etc. | — |
Countries
Japan
Contacts
Public ContactShohei Horie
TeleBio Inc. Manufacturing Division
Outcome results
None listed